Structure-based discovery and in-parallel optimization of novel competitive inhibitors of thymidylate synthase

被引:59
作者
Tondi, D
Slomczynska, U
Costi, MR
Watterson, DM
Ghelli, S
Shoichet, BK [1 ]
机构
[1] Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA
[2] Univ Modena, Dipartimento Sci Farmaceut, I-41100 Modena, Italy
[3] Univ Modena, Dipartimento Chim, I-41100 Modena, Italy
来源
CHEMISTRY & BIOLOGY | 1999年 / 6卷 / 05期
关键词
computer-based inhibitor design; enzyme specificity; in parallel synthesis; structure-based drug design;
D O I
10.1016/S1074-5521(99)80077-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The substrate sites of enzymes are attractive targets for structure-based inhibitor design. Two difficulties hinder efforts to discover and elaborate new (nonsubstrate-like) inhibitors for these sites. First, novel inhibitors often bind at nonsubstrate sites. Second, a novel scaffold introduces chemistry that is frequently unfamiliar, making synthetic elaboration challenging, Results: In an effort to discover and elaborate a novel scaffold for a substrate site, we combined structure-based screening with in-parallel synthetic elaboration. These techniques were used to find new inhibitors that bound to the folate site of Lactobacillus casei thymidylate synthase (LcTS), an enzyme that is a potential target for proliferative diseases, and is highly studied, The available chemicals directory was screened, using a molecular-docking computer program, for molecules that complemented the three-dimensional structure of this site. Five high-ranking compounds were selected for testing. Activity and docking studies led to a derivative of one of these, dansyltyrosine (K-i 65 mu M). Using solid-phase in-parallel techniques 33 derivatives of this lead were synthesized and tested. These analogs are dissimilar to the substrate but bind competitively with it. The most active analog had a K-i of 1.3 mu M. The tighter binding inhibitors were also the most specific for LcTS versus related enzymes, Conclusions: TS can recognize inhibitors that are dissimilar to, but that bind competitively with, the folate substrate. Combining structure-based discovery with in-parallel synthetic techniques allowed the rapid elaboration of this series of compounds. More automated versions of this approach can be envisaged.
引用
收藏
页码:319 / 331
页数:13
相关论文
共 58 条
[1]   DESIGN OF ENZYME-INHIBITORS USING ITERATIVE PROTEIN CRYSTALLOGRAPHIC ANALYSIS [J].
APPELT, K ;
BACQUET, RJ ;
BARTLETT, CA ;
BOOTH, CLJ ;
FREER, ST ;
FUHRY, MAM ;
GEHRING, MR ;
HERRMANN, SM ;
HOWLAND, EF ;
JANSON, CA ;
JONES, TR ;
KAN, CC ;
KATHARDEKAR, V ;
LEWIS, KK ;
MARZONI, GP ;
MATTHEWS, DA ;
MOHR, C ;
MOOMAW, EW ;
MORSE, CA ;
OATLEY, SJ ;
OGDEN, RC ;
REDDY, MR ;
REICH, SH ;
SCHOETTLIN, WS ;
SMITH, WW ;
VARNEY, MD ;
VILLAFRANCA, JE ;
WARD, RW ;
WEBBER, S ;
WEBBER, SE ;
WELSH, KM ;
WHITE, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (07) :1925-1934
[2]   MOLECULAR-BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY [J].
AREVALO, JH ;
TAUSSIG, MJ ;
WILSON, IA .
NATURE, 1993, 365 (6449) :859-863
[3]  
ARIENS EJ, 1971, DRUG DESIGN, V1, P177
[4]   STRUCTURAL-ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES [J].
BADGER, J ;
MINOR, I ;
OLIVEIRA, MA ;
SMITH, TJ ;
ROSSMANN, MG .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (01) :1-19
[5]   Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display [J].
Ballinger, MD ;
Jones, JT ;
Lofgren, JA ;
Fairbrother, WJ ;
Akita, RW ;
Sliwkowski, MX ;
Wells, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11675-11684
[6]  
BARTLETT PA, 1989, MOL RECOGNITION CHEM, P182
[7]   AN EFFICIENT METHOD FOR ANCHORING FMOC-AMINO ACIDS TO HYDROXYL-FUNCTIONALIZED SOLID SUPPORTS [J].
BLANKEMEYERMENGE, B ;
NIMTZ, M ;
FRANK, R .
TETRAHEDRON LETTERS, 1990, 31 (12) :1701-1704
[8]   INHIBITION OF THE FUSION-INDUCING CONFORMATIONAL CHANGE OF INFLUENZA HEMAGGLUTININ BY BENZOQUINONES AND HYDROQUINONES [J].
BODIAN, DL ;
YAMASAKI, RB ;
BUSWELL, RL ;
STEARNS, JF ;
WHITE, JM ;
KUNTZ, ID .
BIOCHEMISTRY, 1993, 32 (12) :2967-2978
[9]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO
[10]  
2-6